These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9766246)

  • 1. Transdermal alniditan delivery by skin electroporation.
    Jadoul A; Lecouturier N; Mesens J; Caers W; Préat V
    J Control Release; 1998 Aug; 54(3):265-72. PubMed ID: 9766246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal permeation of alniditan by iontophoresis: in vitro optimization and human pharmacokinetic data.
    Jadoul A; Mesens J; Caers W; de Beukelaar F; Crabbé R; Préat V
    Pharm Res; 1996 Sep; 13(9):1348-53. PubMed ID: 8893273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks.
    Roon KI; Soons PA; Uitendaal MP; de Beukelaar F; Ferrari MD
    Br J Clin Pharmacol; 1999 Mar; 47(3):285-90. PubMed ID: 10215753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors.
    Vanbever R; LeBoulengé E; Préat V
    Pharm Res; 1996 Apr; 13(4):559-65. PubMed ID: 8710746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal permeation of neutral molecules by skin electroporation.
    Vanbever R; Leroy MA; Préat V
    J Control Release; 1998 Aug; 54(3):243-50. PubMed ID: 9766244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecules as novel transdermal transport enhancers for skin electroporation.
    Vanbever R; Prausnitz MR; Préat V
    Pharm Res; 1997 May; 14(5):638-44. PubMed ID: 9165536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of timolol by electroporation through human skin.
    Denet AR; Préat V
    J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.
    Goldstein J; Dahlöf CG; Diener HC; Olesen J; Schellens R; Senard JM; Simard D; Steiner TJ
    Cephalalgia; 1996 Nov; 16(7):497-502. PubMed ID: 8933995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones.
    Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
    J Control Release; 2000 May; 66(2-3):127-33. PubMed ID: 10742574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of migraine attacks with intranasal alniditan: an open study.
    Diener HC; Louis P; Schellens R; De Beukelaar F;
    Cephalalgia; 2001 Mar; 21(2):140-4. PubMed ID: 11422097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronically facilitated transdermal delivery of human parathyroid hormone (1-34).
    Medi BM; Singh J
    Int J Pharm; 2003 Sep; 263(1-2):25-33. PubMed ID: 12954177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrically modulated transdermal delivery of fentanyl.
    Conjeevaram R; Banga AK; Zhang L
    Pharm Res; 2002 Apr; 19(4):440-4. PubMed ID: 12033377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal iontophoresis of sodium nonivamide acetate. V. Combined effect of physical enhancement methods.
    Fang JY; Hwang TL; Huang YB; Tsai YH
    Int J Pharm; 2002 Mar; 235(1-2):95-105. PubMed ID: 11879744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced transdermal delivery of tetracaine by electroporation.
    Hu Q; Liang W; Bao J; Ping Q
    Int J Pharm; 2000 Jul; 202(1-2):121-4. PubMed ID: 10915934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
    Sung KC; Fang JY; Wang JJ; Hu OY
    Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of optimized electroporation enhances the transdermal efficiency of sinomenine hydrochloride for treating arthritis in vitro and in clinic.
    Feng S; Zhu L; Huang Z; Wang H; Li H; Zhou H; Lu L; Wang Y; Liu Z; Liu L
    Drug Des Devel Ther; 2017; 11():1737-1752. PubMed ID: 28670109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels.
    Fang JY; Sung KC; Wang JJ; Chu CC; Chen KT
    J Pharm Pharmacol; 2002 Oct; 54(10):1329-37. PubMed ID: 12396293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro.
    Bommannan DB; Tamada J; Leung L; Potts RO
    Pharm Res; 1994 Dec; 11(12):1809-14. PubMed ID: 7899247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The enhancing effect of electroporation and iontophoresis on the permeation of insulin through human skin].
    Pan Y; Zhao HY; Zheng JM
    Yao Xue Xue Bao; 2002 Aug; 37(8):649-52. PubMed ID: 12567783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach.
    Denet AR; Ucakar B; Préat V
    Pharm Res; 2003 Dec; 20(12):1946-51. PubMed ID: 14725358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.